FDA inspection
Biocon Biologics India Limited: FDA inspection ending Apr 7, 2017
FDA inspection 1011627 · Voluntary Action Indicated (VAI) · Bengaluru
Key facts
| Inspection ID | 1011627 |
|---|---|
| Firm | Biocon Biologics India Limited |
| FEI number | 3003981475 |
| Address | Special Economic Zone, Plot No. 2, 3, 4&5, Phase Iv, Bommasandra-Jigani Link Road, Bommasandra Post |
| City | Bengaluru |
| Fiscal year | 2017 |
| Inspection end date | Apr 7, 2017 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data